Jian Ding
Voorzitter bij Shanghai Haihe Biopharma Co., Ltd.
Profiel
Jian Ding is currently the Chairman at Shanghai Haihe Biopharma Co., Ltd.
since 2011.
Prior to this, he worked as an Independent Director at Hunan Jingfeng Pharmaceutical Co., Ltd.
from 2014 to 2021.
Actieve functies van Jian Ding
| Bedrijven | Functie | Begin |
|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Voorzitter | 01-03-2011 |
Eerdere bekende functies van Jian Ding
| Bedrijven | Functie | Einde |
|---|---|---|
| HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. | Directeur/Bestuurslid | 26-01-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
